|
|
News Breaks | | | | October 3, 2012 | | 07:07 EDT |  | SRPT | Sarepta Therapeutics receives notice from DoD for termination of Ebola program
Sarepta Therapeutics received notice from the U.S. Department of Defense, or DoD, that the Ebola portion of the company's contract for the advanced development of hemorrhagic fever virus therapeutics was terminated for the convenience of the government due to funding constraints. The DoD's Joint Project Manager Transformational Medical Technologies, or JPM-TMT, awarded this contract in July 2010 to advance a platform capability for treating both Marburg virus and Ebola virus. The Marburg portion of the contract remains in effect. | |
|
News For SRPT From The Last 14 Days Check below for free stories on SRPT the last two weeks. |
|
|
| May 21, 2013 | | 07:34 EDT |  | SRPT | UBS to host a conference
 Subscribe for More Information | | | May 16, 2013 | | 07:29 EDT | | SRPT | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. | | | May 9, 2013 | | 12:21 EDT | | SRPT | Sarepta climbs after saying documents to be submitted this month
Subscribe for More Information | | | 07:29 EDT |  | SRPT | Sarepta reports Q1 EPS (41c), consensus (62c)
Reports Q1 revenue $4.5M, consensus $5.85M. | |
|
|
|
|
|
|
